Inventor · disambiguated record
Donald F. Hunt
Also filed as: HUNT DONALD · HUNT DONALD F
32 granted patents·22 pending applications·476 citations·filing 1976–2022
97Inventor score
Top patents by PatentIndex Score
54 records- 0197US7749769B2Simultaneous sequence analysis of amino- and carboxy-terminiUNIV VIRGINIA·Filed 2005·Granted Jul 6, 2010·45 cites·23 claims
- 0297US7534622B2Electron transfer dissociation for biopolymer sequence mass spectrometric analysisUNIV VIRGINIA·Filed 2005·Granted May 19, 2009·81 cites·35 claims
- 0397US4136280APositive and negative ion recording system for mass spectrometerUNIV VIRGINIA·Filed 1977·Granted Jan 23, 1979·70 cites·12 claims
- 0487US4066894APositive and negative ion recording system for mass spectrometerUNIV VIRGINIA·Filed 1976·Granted Jan 3, 1978·24 cites·13 claims
- 0586US6315905B1Method for structural characterization of biological moieties through HPLC separationUNIV VIRGINIA·Filed 2000·Granted Nov 13, 2001·30 cites·5 claims
- 0686US6139734AApparatus for structural characterization of biological moieties through HPLC separationUNIV VIRGINIA·Filed 1998·Granted Oct 31, 2000·77 cites·6 claims
- 0784US7704507B2Anticancer vaccine and diagnostic methods and reagentsUNIV PITTSBURGH·Filed 2006·Granted Apr 27, 2010·7 cites·3 claims
- 0883US4175234AApparatus for producing ions of thermally labile or nonvolatile solidsVIRGINIA UNIVERSITY·Filed 1978·Granted Nov 20, 1979·21 cites·16 claims
- 0977US8119984B2Method and apparatus for generation of reagent ions in a mass spectrometerSHABANOWITZ JEFFREY·Filed 2009·Granted Feb 21, 2012·7 cites·29 claims
- 1076US9561266B2Target peptides for immunotherapy and diagnosticsU VA LICENSING & VENTURES GROUP·Filed 2013·Granted Feb 7, 2017·5 cites·18 claims
- 1175US7026167B2Systems and methods for the analysis of protein phosphorylationUNIV VIRGINIA·Filed 2002·Granted Apr 11, 2006·9 cites·18 claims
- 1272US10682399B2Target peptides for colorectal cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2013·Granted Jun 16, 2020·2 cites·101 claims
- 1372US7008922B2H-Y antigenUNIV LEIDEN·Filed 2002·Granted Mar 7, 2006·3 cites·3 claims
- 1471US12347665B2Rapid identification and sequence analysis of intact proteins in complex mixturesUNIV VIRGINIA PATENT FOUNDATION·Filed 2022·Granted Jul 1, 2025·0 cites·11 claims
- 1571US12042530B2Target peptides for immunotherapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Granted Jul 23, 2024·0 cites·7 claims
- 1671US10640535B2Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategiesAGENUS INC·Filed 2013·Granted May 5, 2020·2 cites·55 claims
- 1771US6558671B1Cysteine-depleted peptides recognized by A3-restricted cytotoxic lymphocytes, and uses thereforUNIV VIRGINIA·Filed 1998·Granted May 6, 2003·25 cites·12 claims
- 1871US2023059301A1Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategiesAGENUS INC·Filed 2022·Application pending·0 cites
- 1968US6878375B1HA-1 antigenUNIV LEIDEN·Filed 2000·Granted Apr 12, 2005·3 cites·6 claims
- 2067US4156814AApparatus for producing ions of thermally labile or nonvolatile solidsVIRGINIA UNIVERSITY·Filed 1977·Granted May 29, 1979·11 cites·8 claims
- 2167US2022041655A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisAGENUS INC·Filed 2021·Application pending·0 cites
- 2263US8692187B2Electron transfer dissociation for biopolymer sequence analysisHUNT DONALD F·Filed 2012·Granted Apr 8, 2014·2 cites·24 claims
- 2360US11414458B2Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategiesAGENUS INC·Filed 2020·Granted Aug 16, 2022·0 cites·9 claims
- 2460US2021154279A1Target peptides for colorectal cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 2560US2022211828A1Target peptides for ovarian cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Application pending·0 cites
- 2659US2016000893A1Target peptides for ovarian cancer therapy and diagnosticsUniv Virginia Patent Found·Filed 2013·Application pending·0 cites
- 2758US6660276B1Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses thereforUNIV VIRGINIA·Filed 1994·Granted Dec 9, 2003·21 cites·12 claims
- 2858US2009230302A1Electron Transfer Dissociation for Biopolymer Sequence AnalysisUNIV VIRGINIA·Filed 2009·Application pending·0 cites
- 2957US7019112B1Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses thereforUNIV VIRGINIA·Filed 1997·Granted Mar 28, 2006·12 cites·5 claims
- 3057US2008206268A1HA-1 epitopes and uses thereofGOULMY ELSA A J M·Filed 2007·Application pending·0 cites
- 3155US7205119B2HA-1 antigenUNIV LEIDEN·Filed 2004·Granted Apr 17, 2007·0 cites·11 claims
- 3252US2023176069A1Mitigating concentration effects of antibody digestion for complete sequence coverageUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Application pending·0 cites
- 3351US2004092446A1HA-1 epitopes and uses thereofFiled 2003·Application pending·0 cites
- 3451US2006159690A1H-Y antigenUNIV LEIDEN·Filed 2005·Application pending·0 cites
- 3550US6521598B1H-Y antigenUNIV LEIDEN·Filed 1996·Granted Feb 18, 2003·5 cites·3 claims
- 3650US2018066017A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisAGENUS INC·Filed 2017·Application pending·0 cites
- 3749US8758767B2Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereofDILORENZO TERESA P·Filed 2004·Granted Jun 24, 2014·1 cites·3 claims
- 3849US8211436B2Anticancer vaccine and diagnostic methods and reagentsFINN OLIVERA J·Filed 2010·Granted Jul 3, 2012·0 cites·2 claims
- 3949US2003143647A1Anticancer vaccine and diagnostic methods and reagentsUNIV PITTSBURGH·Filed 2002·Application pending·0 cites
- 4048US2022265791A1Target peptides for cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 4148US2017333541A1Target peptides for immunotherapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2016·Application pending·0 cites
- 4247US2013259883A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisHUNT DONALD F·Filed 2011·Application pending·0 cites
- 4347US2022387567A1Compositions and methods for treating diseases and disorders associated with aberrant regulation of proteinsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 4446US11538675B2Rapid identification and sequence analysis of intact proteins in complex mixturesHUNT DONALD F·Filed 2017·Granted Dec 27, 2022·0 cites·3 claims
- 4545US5770201AHA-2 antigenic peptideRIJSUNIVERSITEIT TE LEIDEN·Filed 1994·Granted Jun 23, 1998·13 cites·11 claims
- 4644US2002192229A1MHC class I associated peptides for prevention and treatment of tuberculosisFiled 2001·Application pending·0 cites
- 4744US2006073517A1Post-translational modifications of proteins as regulatory switchesALLIS C D·Filed 2004·Application pending·0 cites
- 4843US2003211116A1Mhc peptides over-expressed on prostate cancer cells and methods of useFiled 2001·Application pending·0 cites
- 4941US10281473B2Compositions and methods for analysis of protein sequences and post-translational modificationsUNIV VIRGINIA PATENT FOUNDATION·Filed 2015·Granted May 7, 2019·0 cites·39 claims
- 5038US2019015494A1Identification of class i mhc associated glycopeptides as targets for cancer immunotherapyUNIV VIRGINIA PATENT FOUNDATION·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →